cp wire

CP Wire Articles

AstraZeneca and Merck Present Updated Overall Survival Data for Lynparza in gBRCA-mutated HER2-Negative Metastatic Breast Cancer

AstraZeneca and Merck today presented data from the Phase 3 OlympiAD trial showing the final overall survival (OS) results for Lynparza in metastatic breast cancer. The trial compared Lynparza ... read more

Mon, 04/16/18 - 01:21 am
Keytruda Adjuvant Therapy Study Shows Reduced the Risk of Disease Recurrence or Death by More Than 40 Percent Compared to Placebo in Stage III Melanoma

Merck today announced findings from the Phase 3 EORTC1325/KEYNOTE-054 trial investigating Keytruda, Merck’s anti-PD-1 therapy, as adjuvant therapy in resected, high-risk stage III melanoma. Study... read more

Sun, 04/15/18 - 01:00 pm
The First Successful Transfer of DNA Sequence Over the Ethereum Blockchain


DNAtix has completed the first Proof Of Concept (POC) test by transferring the complete genome sequence of a virus - Enterobacteria phage phiX174 sensu lato - over the Ethereum Blockchain. The... read more

Sun, 04/15/18 - 12:47 pm
NGM Bio Releases Promising Results From Phase 2 Study Of NGM282 In NASH

NGM Bio today announced data from a Phase 2 study of its lead product candidate, NGM282, demonstrating clinically meaningful improvements in histological measures of disease in nonalcoholic... read more

Sat, 04/14/18 - 10:09 am
Intercept Presents Data form Ph III Substudy That Supports Obeticholic Acid’s Ability to Reverse or Stabilize Fibrosis and Cirrhosis in Primary Biliary Cholangitis (PBC) Patients

Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver... read more

Fri, 04/13/18 - 12:52 pm

Pages